Industries > Pharma > Molecular Diagnostics Market Report 2020-2030

Molecular Diagnostics Market Report 2020-2030

Molecular Diagnostics Market Report 2020-2030: By Products and Services (Instruments, Reagents & Kits, Software and Services), Technology (DNA Microarray, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), Other Technologies), Application (Genetic Tests, Infectious Diseases, Oncology, Other Applications), End User (Hospitals & Academics, Research Laboratories, Other End Users) and Geography

PAGES: 174
PRODUCT CODE: PHA0543
SUBMARKET:

Clear
WOOCS 2.2.1
SKU: PHA0543 Category: Tags: , ,

Molecular Diagnostics– our new study reveals trends, R&D progress, and predicted revenues
Where is the Molecular Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 166-page report provides 35 tables, 141 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Molecular Diagnostics market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 4 segmentations of the Molecular Diagnostics Market, with forecasts for 3 Products and Services, 5 Technologies, 4 Applications, 3 End Users, each forecasted at a global and regional level.

Global Molecular Diagnostics Market by Products and Services
– Instruments
– Reagents & Kits
– Software and Services

Global Molecular Diagnostics Market by Technology
– DNA Microarray
– In Situ Hybridization
– Isothermal Nucleic Acid Amplification Technology (INAAT)
– DNA Sequencing & Next-Generation Sequencing (NGS)
– Other Technologies

Global Molecular Diagnostics Market by Application
– Genetic Tests
– Infectious Diseases
– CT/NG
– HAIS
– Hepatitis
– HIV
– HPV
– Influenza
– Tuberculosis
– Other Infectious Diseases
– Oncology
– Breast Cancer
– Colorectal Cancer
– Lung Cancer
– Prostate Cancer
– Other Cancers
– Other Applications

Global Molecular Diagnostics Market by End User
– Hospitals & Academics
– Research Laboratories
– Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 21 leading national markets:

– North America:
– US
– Canada

– Latin America:
– Brazil
– Mexico
– Rest of Latin America

– Western Europe:
– Germany
– The UK
– Italy
– France
– Spain
– Nordic
– Benelux
– Rest of Western Europe

– Eastern Europe:
– Russia
– Poland
– Rest of Eastern Europe

– Asia-Pacific:
– Japan
– China
– India
– Australia & New Zealand
– ASEAN
– Rest of Asia-Pacific

– MEA:
– GCC Countries
– South Africa
– Northern Africa
– Rest of MEA

The report also includes profiles and for some of the leading companies in the Molecular Diagnostics Market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2030.

Leading companies and the potential for market growth
Overall world revenue for Molecular Diagnostics will surpass $8.5 bn in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Molecular Diagnostics Market report helps you
In summary, our 166-page report provides you with the following knowledge:

– Revenue forecasts to 2030 for 4 segmentations of the Molecular Diagnostics Market, with forecasts for 3 Products and Services, 5 Technologies, 4 Applications, 3 End Users, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

– Revenue forecasts to 2030 for 6 regional and 21 key national markets – See forecasts for the Molecular Diagnostics market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.

– Stimulates and restrains companies and the market

– Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the major companies involved in the Molecular Diagnostics market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Molecular Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today The Molecular Diagnostics Market Forecast 2020-2030: Revenue Prospects by Products and Services (Instruments, Reagents & Kits, Software and Services), Technology (DNA Microarray, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), Other Technologies), Application (Genetic Tests, Infectious Diseases, Oncology, Other Applications), End User (Hospitals & Academics, Research Laboratories, Other End Users), and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Molecular Diagnostics Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Molecular Diagnostics Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

READ

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

READ

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

READ

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

READ

Categories

Category